U-31889 |
XANAX XR |
ALPRAZOLAM |
U 31,889 |
ALPRAZOLAM CIV |
XANAX |
NIRAVAM |
NIRAVAM® |
XANAX® |
8-CHLORO-1-METHYL-6-PHENYL-4H-S-TRIAZOLO(4,3-A)(1,4)BENZODIAZEPINE |
KENTIUM |
ALZAM |
drugbank:00404 |
chemidplus:28981-97-7 |
chembl:CHEMBL661 |
pubchem.compound:2118 |
rxcui:596 |
FDA Approval | approved |
Drug Class | Small Molecule |
Drug Indications | anxiolytic, sedative,hypnotic |
Drug Class | anti-anxiety agents |
Year of Approval | 1981 |
Drug Class | hypnotics and sedatives |
n/a |
Trial Name | alprazolam,Xanax, Xanax XR |
Novel drug target | Established target |
Trial Name | AZ-002, Staccato alprazolam |
n/a |
Trial Name | alprazolam,Xanax, Xanax XR |
Novel drug target | Established target |
Trial Name | AZ-002, Staccato alprazolam |
ligand |
positive modulator (activating) |
allosteric modulator |
Direct Interaction | yes |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Trial Name | AZ-002, Staccato alprazolam |
positive modulator (activating) |
Trial Name | alprazolam,Xanax, Xanax XR |
Novel drug target | Established target |
Trial Name | AZ-002, Staccato alprazolam |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
Trial Name | alprazolam,Xanax, Xanax XR |
positive modulator (activating) |
Trial Name | alprazolam,Xanax, Xanax XR |
Novel drug target | Established target |
Trial Name | AZ-002, Staccato alprazolam |
positive modulator (activating) |
Trial Name | AZ-002, Staccato alprazolam |
Novel drug target | Established target |
Trial Name | alprazolam,Xanax, Xanax XR |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
Trial Name | AZ-002, Staccato alprazolam |
positive modulator (activating) |
Trial Name | alprazolam,Xanax, Xanax XR |
Novel drug target | Established target |
Trial Name | AZ-002, Staccato alprazolam |
positive modulator (activating) |
Trial Name | alprazolam,Xanax, Xanax XR |
Novel drug target | Established target |
Trial Name | AZ-002, Staccato alprazolam |
positive modulator (activating) |
Trial Name | alprazolam,Xanax, Xanax XR |
Novel drug target | Established target |
Trial Name | AZ-002, Staccato alprazolam |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
Trial Name | alprazolam,Xanax, Xanax XR |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
Trial Name | alprazolam,Xanax, Xanax XR |
positive modulator (activating) |
Trial Name | alprazolam,Xanax, Xanax XR |
Novel drug target | Established target |
Trial Name | AZ-002, Staccato alprazolam |
positive modulator (activating) |
allosteric modulator |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
Trial Name | AZ-002, Staccato alprazolam |
positive modulator (activating) |
allosteric modulator |
Trial Name | alprazolam,Xanax, Xanax XR |
Novel drug target | Established target |
Trial Name | AZ-002, Staccato alprazolam |
positive modulator (activating) |
allosteric modulator |
Trial Name | AZ-002, Staccato alprazolam |
Novel drug target | Established target |
Trial Name | alprazolam,Xanax, Xanax XR |
n/a |
Trial Name | AZ-002, Staccato alprazolam |
Novel drug target | Established target |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
ALPRAZOLAM | Primary Drug Name |
Drug Class | hypnotics and sedatives |
Year of Approval | 1981 |
Drug Class | anti-anxiety agents |
Drug Indications | anxiolytic, sedative,hypnotic |
Drug Class | Small Molecule |
FDA Approval | approved |
C227 | NCI drug code |
CHEMBL661 | ChEMBL Drug ID |
D0L9GG | TTD Drug ID |